Insulin resistance and glucose homeostasis in peritoneal dialysis

Area of Science:

• Nephrology
• Endocrinology
• Cardiology

Background:

• Cardiovascular disease (CVD) is the leading cause of mortality in peritoneal dialysis (PD) patients.
• Chronic kidney disease (CKD) is associated with significant alterations in glucose and insulin homeostasis, leading to insulin resistance.
• Traditional and nontraditional CVD risk factors are prevalent in CKD and PD populations.

Purpose of the Study:

• To explore the complex interplay between insulin resistance, glucose metabolism, and cardiovascular risk in PD patients.
• To identify the contributing factors to metabolic abnormalities in CKD and PD.
• To emphasize the impact of PD dialysis fluid on metabolic derangements.

Main Methods:

• Review of existing literature on metabolic disturbances in CKD and PD.
• Analysis of factors contributing to insulin resistance in the context of renal disease.
• Evaluation of the metabolic consequences of glucose exposure from PD solutions.

Main Results:

• Insulin resistance is a common complication in CKD, exacerbated by factors like anemia, dyslipidemia, uremia, and inflammation.
• PD patients exhibit pronounced insulin resistance and dyslipidemia, contributing to hypertension and atherosclerosis.
• Glucose from PD solutions intensifies metabolic abnormalities, despite dialysis offering partial correction.

Conclusions:

• Insulin resistance and impaired glucose metabolism are frequent in CKD and PD patients.
• The use of glucose-containing PD solutions can exacerbate harmful metabolic consequences.
• Novel therapeutic strategies targeting metabolic disorders are crucial for improving survival in PD patients.